Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival (Q35599471)
Jump to navigation
Jump to search
scientific article published on 13 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival |
scientific article published on 13 January 2015 |
Statements
1 reference
Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival (English)
1 reference
Jennifer Eremin
1 reference
Ged Cowley
1 reference
Leslie G Walker
1 reference
Elisabeth Murray
1 reference
Monika Stovickova
1 reference
Oleg Eremin
1 reference
13 January 2015
1 reference
1 reference
4
1 reference
9
1 reference
13 January 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference